PNGAF (The Precision Peptide Co) Scaled Net Operating Assets: -0.11 (As of Jan. 2026)


PNGAF The Precision Peptide Co Inc PNGAF
21 GF Score
Price $0.34
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co Scaled Net Operating Assets?

The Precision Peptide Co PNGAF -1.93% 21 Scaled Net Operating Assets is -0.11 as of Jan. 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

The Precision Peptide Co's operating assets for the quarter that ended in Jan. 2026 was $0.17 Mil. The Precision Peptide Co's operating liabilities for the quarter that ended in Jan. 2026 was $0.28 Mil. The Precision Peptide Co's Total Assets for the quarter that ended in Oct. 2025 was $0.95 Mil. Therefore, The Precision Peptide Co's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2026 was -0.11.

The Precision Peptide Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Scaled Net Operating Assets Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Scaled Net Operating Assets
0.31 0.10 -0.38 -3.50 -0.16

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.60 10.36 0.65 -0.01 -0.11

PNGAF vs KHC, GIS: Scaled Net Operating Assets Comparison

For the Packaged Foods subindustry, The Precision Peptide Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Precision Peptide Co Scaled Net Operating Assets vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where The Precision Peptide Co's Scaled Net Operating Assets falls into.


PNGAF
21GF Score
The Precision Peptide Co Inc PNGAF
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

The Precision Peptide Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2025 )
=(Operating Assets (A: Oct. 2025 )-Operating Liabilities (A: Oct. 2025 ))/Total Assets (A: Oct. 2024 )
=(0.266-0.287)/0.132
=-0.16

where

Operating Assets(A: Oct. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.952 - 0.686
=0.266

Operating Liabilities(A: Oct. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.287 - 0 - 0
=0.287

The Precision Peptide Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2026 )
=(Operating Assets (Q: Jan. 2026 )-Operating Liabilities (Q: Jan. 2026 ))/Total Assets (Q: Oct. 2025 )
=(0.172-0.277)/0.952
=-0.11

where

Operating Assets(Q: Jan. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.473 - 0.301
=0.172

Operating Liabilities(Q: Jan. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.277 - 0 - 0
=0.277

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.11 mean?
The Precision Peptide Co (PNGAF) has a Scaled Net Operating Assets of -0.11 as of Jan. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Scaled Net Operating Assets too high?
The Precision Peptide Co's current Scaled Net Operating Assets is -0.11. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Scaled Net Operating Assets compare to KHC and GIS?
The Precision Peptide Co's Scaled Net Operating Assets of -0.11 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Consumer Packaged Goods company?
A good Scaled Net Operating Assets depends on the Consumer Packaged Goods industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on The Precision Peptide Co and its competitors. The Precision Peptide Co's current Scaled Net Operating Assets is -0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Scaled Net Operating Assets of -0.11. The current Scaled Net Operating Assets is -0.11. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Scaled Net Operating Assets is -0.11 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score

Get the complete analysis for PNGAF

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price